首页 | 本学科首页   官方微博 | 高级检索  
检索        

乳腺癌耐药蛋白重组腺病毒干扰载体构建及其干扰作用的观察
引用本文:唐勇,刘传亮,窦建新,蔡晓珊,刘静,陈伟娟.乳腺癌耐药蛋白重组腺病毒干扰载体构建及其干扰作用的观察[J].中华肿瘤防治杂志,2008,15(18):1374-1376.
作者姓名:唐勇  刘传亮  窦建新  蔡晓珊  刘静  陈伟娟
作者单位:1. 潍坊市人民医院保健三科,山东,潍坊,261041
2. 潍坊医学院病理学教研室,山东,潍坊,261053
摘    要:目的:观察腺病毒加载的RNAi对乳腺癌耐药蛋白(BCRP)介导的多药耐药的逆转。方法:构建干扰BCRP mRNA的腺病毒载体,采用细胞毒性实验和外排实验检测pAd-BCRP感染后,耐药细胞后的逆转情况。结果:pAd-BCRP可将B37/MX细胞对米托蒽醌的耐药指数从978降低至75(92.3%逆转)。外排实验结果显示,感染pAd-BCRP和未感染的B37/MX细胞外排1 h后细胞内的米托蒽醌的荧光强度分别为56.4和12.8。结论:pAd-BCRP能显著降低B37/MX细胞中BCRP的表达并抑制BCRP的功能。

关 键 词:乳腺肿瘤  药物耐受性  肿瘤蛋白质类  RNA干扰  腺病毒科  遗传载体

Construction of RNAi recombinated adenovirus targeting BCRP and its inhibitive effects on BCRP
TANG Yong,LIU Chuan-liang,DOU Jian-xin,CAI Xiao-shan,LIU Jing,CHEN Wei-juan.Construction of RNAi recombinated adenovirus targeting BCRP and its inhibitive effects on BCRP[J].Chinese Journal of Cancer Prevention and Treatment,2008,15(18):1374-1376.
Authors:TANG Yong  LIU Chuan-liang  DOU Jian-xin  CAI Xiao-shan  LIU Jing  CHEN Wei-juan
Abstract:OBJECTIVE:To observe the reversing effects of RNAi deliveried by adenovirus on BCRP mediated multidrug resistance.METHODS: RNAi adenovirus targeting breast cancer resistant protein(BCRP) was constructed.The reversal of BCRP was detected by cytotoxicity assays and efflux assays after infection with pAd-BCRP.RESULTS: The multidrug resistance index decreased from 987 to 75(92.3% reverse).The results of efflux assay showed that,after an hour's discharge,the fluorescence intensities were 56.4 and 12.8 in the B37/MX cells infected with adenovirus and without the infection,respectivly.CONCLUSION: RNAi deliveried by adenovrius can decrease the expression of BCRP and reverse MDR mediated by BCRP.
Keywords:breast neoplasms  drug tolerance  neoplasm proteins  RNA interference  adenoviridae  genetic vectors
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号